Work

Zanubrutinib with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory non–germinal center B-cell lymphoma

Year: 2026

Type: article

Study design: Observational Study

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.1080/10428194.2026.2735668

Authors: Wei Chen, Fang Yuan, Jieyu Xu, Shuailing Peng, Xi Chen, Shuiyun Han, Haifeng Yu

Institutions: Dongyang People's Hospital, Second Affiliated Hospital of Zhejiang University, Zhejiang University, Zhejiang Cancer Hospital

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7224136551

FWCI:

Cites: 33

Cited by:

Related to: 10